• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Rare variant with insidious presentation leads to a delayed diagnosis of X-linked hypophosphatemia.罕见的隐匿性变异导致 X 连锁低磷血症的诊断延迟。
BMJ Case Rep. 2021 May 19;14(5):e240336. doi: 10.1136/bcr-2020-240336.
2
X-Linked HypophosphatemiaX连锁低磷血症
3
X-linked hypophosphatemic rickets: a new mutation.X 连锁低磷血症性佝偻病:一种新的突变。
J Bras Nefrol. 2021 Apr-Jun;43(2):279-282. doi: 10.1590/2175-8239-JBN-2020-0027.
4
Analysis of 2 novel mutations of PHEX gene inducing X-linked dominant hypophosphatemia rickets in 2 families: Two case reports.2个家庭中诱导X连锁显性低磷血症佝偻病的PHEX基因2种新突变分析:2例病例报告
Medicine (Baltimore). 2018 Aug;97(31):e11453. doi: 10.1097/MD.0000000000011453.
5
Mutational analysis of patients with FGF23-related hypophosphatemic rickets.成纤维细胞生长因子 23 相关低磷血症性佝偻病患者的突变分析。
Eur J Endocrinol. 2012 Aug;167(2):165-72. doi: 10.1530/EJE-12-0071. Epub 2012 May 10.
6
Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.比利时 X 连锁低磷血症诊断和管理的共识建议。
Front Endocrinol (Lausanne). 2021 Mar 19;12:641543. doi: 10.3389/fendo.2021.641543. eCollection 2021.
7
Unusually severe hypophosphatemic rickets caused by a novel and complex re-arrangement of the PHEX gene.由PHEX基因的一种新型复杂重排引起的异常严重的低磷性佝偻病。
Am J Med Genet A. 2014 Nov;164A(11):2931-7. doi: 10.1002/ajmg.a.36721. Epub 2014 Aug 13.
8
X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3'-UTR Mutation c.*231A>G (A Retrospective Case-Control Study).X连锁低磷血症:与PHEX 3'-UTR突变c.*231A>G相关的独特轻症疾病(一项回顾性病例对照研究)
J Bone Miner Res. 2020 May;35(5):920-931. doi: 10.1002/jbmr.3955. Epub 2020 Mar 10.
9
X-linked hypophosphatemic rickets: case report.X连锁低磷性佝偻病:病例报告。
Srp Arh Celok Lek. 2014 Jan-Feb;142(1-2):75-8. doi: 10.2298/sarh1402075r.
10
A New Mosaic Mutation of PHEX Gene: A Case Report of a Boy with Hypophosphatemic Rickets.一种新的 PHEX 基因突变:一名男性低磷血症性佝偻病患儿的病例报告。
Endocr Metab Immune Disord Drug Targets. 2023;23(9):1235-1239. doi: 10.2174/1871530323666230227142202.

引用本文的文献

1
Asia-Pacific Consensus Recommendations on X-Linked Hypophosphatemia: Diagnosis, Multidisciplinary Management, and Transition From Pediatric to Adult Care.《亚太地区X连锁低磷血症共识推荐:诊断、多学科管理及从儿科到成人护理的过渡》
JBMR Plus. 2023 May 1;7(6):e10744. doi: 10.1002/jbm4.10744. eCollection 2023 Jun.

本文引用的文献

1
Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children.成人和儿童 X 连锁低磷血症(XLH)及其他疾病中使用布罗索尤单抗治疗的临床证据。
Front Endocrinol (Lausanne). 2020 May 28;11:338. doi: 10.3389/fendo.2020.00338. eCollection 2020.
2
Identification of a novel variant in the PHEX gene using targeted gene panel sequencing in a 24-month-old boy with hypophosphatemic rickets.在一名患有低磷血症性佝偻病的24个月大男孩中,通过靶向基因panel测序鉴定PHEX基因中的一种新型变异。
Ann Pediatr Endocrinol Metab. 2020 Mar;25(1):63-67. doi: 10.6065/apem.2020.25.1.63. Epub 2020 Mar 31.
3
Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.成纤维细胞生长因子 23 与普通人群中新发的慢性肾脏病:肾脏和血管终末期疾病预防(PREVEND)研究。
Nephrol Dial Transplant. 2021 Jan 1;36(1):121-128. doi: 10.1093/ndt/gfz266.
4
Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis.X 连锁低磷血症患者的患病率和死亡率:英国真实世界数据分析。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e871-8. doi: 10.1210/clinem/dgz203.
5
Mineralized tissues in hypophosphatemic rickets.低血磷性佝偻病的矿化组织。
Pediatr Nephrol. 2020 Oct;35(10):1843-1854. doi: 10.1007/s00467-019-04290-y. Epub 2019 Aug 8.
6
The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey.X连锁低磷血症的终身影响:疾病负担调查结果
J Endocr Soc. 2019 May 7;3(7):1321-1334. doi: 10.1210/js.2018-00365. eCollection 2019 Jul 1.
7
Burosumab Therapy for X-Linked Hypophosphatemia and Therapeutic Implications for CKD.布罗索尤单抗治疗X连锁低磷血症及对慢性肾脏病的治疗意义
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1097-1099. doi: 10.2215/CJN.15201218. Epub 2019 Jun 6.
8
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.布罗索尤单抗治疗 X 连锁低磷血症儿童:一项随机、活性药物对照、开放标签、3 期临床试验。
Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16.
9
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.X 连锁低磷血症的诊断和管理临床实践建议。
Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5.
10
Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH).儿童和青少年 X 连锁低磷血症(XLH)的诊断、治疗监测和随访。
Metabolism. 2020 Feb;103S:153892. doi: 10.1016/j.metabol.2019.03.009. Epub 2019 Mar 27.

罕见的隐匿性变异导致 X 连锁低磷血症的诊断延迟。

Rare variant with insidious presentation leads to a delayed diagnosis of X-linked hypophosphatemia.

机构信息

Pediatrics, Section of Endocrinology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA

Pediatrics, Section of Endocrinology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.

出版信息

BMJ Case Rep. 2021 May 19;14(5):e240336. doi: 10.1136/bcr-2020-240336.

DOI:10.1136/bcr-2020-240336
PMID:34011663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8137255/
Abstract

A 7-year-old girl without a significant previous medical history was diagnosed with X-linked hypophosphatemic rickets (XLHR) due to a rare, most likely pathogenic, gene variant after a 4-year delayed diagnosis due to mild clinical presentation. At 2 years of age, her intoeing and femoral bowing were attributed to physiologic bowing and borderline vitamin D sufficiency, despite phosphorus not being measured. Hypophosphatemia was eventually detected after incomplete improvement of bowing and leg length discrepancy with suboptimal linear growth. This rare variant (c.1949T>C, p.Leu650Pro) further supported the clinical diagnosis of XLHR. Treatment with burosumab (an anti-FGF23 monoclonal antibody) normalised phosphorus and alkaline phosphatase levels and improved her bowing. The diverse phenotypic presentation of this variant can result in delayed diagnosis and highlights the importance of prompt assessment of phosphorus levels in patients with skeletal deformities to ensure timely recognition and treatment.

摘要

一名 7 岁女孩,既往病史不明显,因临床表现较轻,4 年后才被确诊为 X 连锁低磷性佝偻病(XLHR),这是一种罕见的、很可能具有致病性的基因突变。2 岁时,其内八字和股骨弯曲被归因于生理性弯曲和边缘性维生素 D 充足,尽管当时未检测磷。随着弯曲和腿长差异的不完全改善以及线性生长欠佳,出现低磷血症。该罕见变异(c.1949T>C,p.Leu650Pro)进一步支持 XLHR 的临床诊断。用布罗索尤单抗(一种抗 FGF23 单克隆抗体)治疗后,磷和碱性磷酸酶水平恢复正常,弯曲也得到改善。该变异的不同表型表现可导致诊断延迟,强调了对骨骼畸形患者及时评估磷水平的重要性,以确保及时识别和治疗。